Her research aims to better understand the root causes of dyslexia and spur neural plasticity, or the brain’s ability to adapt, using noninvasive vagus nerve stimulation to improve reading and language skills.
A new study led by MBI researchers has found that using certain FDA-approved medications for addiction treatment was not associated with worse outcomes or additional impairment among participants in Florida’s physician health program.
MBI researcher Dr. Lisa Merlo led a study finding that 95% of health care professionals who completed a PHP said their experience met or exceeded expectations.
In The Conversation, Dr. Carol Mathews discusses the trend of rising ADHD diagnoses and what this means.
Drs. Nancy Padilla-Coreano and Freddyson Martínez-Rivera published a review in the journal Pharmacological Reviews.
In The Conversation, Dr. Carol Mathews explains her new study in Nature Genetics shedding light on the genetics of OCD.
In the largest-ever study into the genetics of OCD, researchers have identified multiple DNA variants that could help predict who is at greater risk of developing it.
Dr. Amanda Elton weighed in on social media's impact on "brain rot" For Women's Health magazine.
Two powerful stories of perseverance took center stage Wednesday evening at an MBI Insights event called “The Resilient Brain: Patient Journeys & Neuroplasticity.”
Dr. Martinez-Rivera's research aims to broaden understanding of adaptive as well as dysfunctional behaviors in conditions such as substance-use disorder, depression and obsessive-compulsive disorder.
